A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

Also called NCT05436028

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 161 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05436028
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05436028. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-23 (actual); primary completion 2024-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement
Condition
Tricuspid Regurgitation
Intervention (Device)
Transcatheter Tricuspid Valve Intervention
Lead sponsor
Jenscare Scientific (class: industry)

Record details

Record id
cardio:ct-nct05436028
Content hash
c02f7506665f74538fce70b65403e9dac84e257bec24a7f139d566a755411eab